ORANGEBURG, NY / ACCESSWIRE / January 22, 2015 / Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the third quarter fiscal 2015, ended December 31, 2014, after the market closes on Wednesday, February 4, 2015. Howard Zauberman, President and Chief Executive Officer, and Gary Siegel, Vice President, Finance, will host a conference call to discuss the results as follows:
Date: Thursday, February 5, 2015
Time: 8:30 AM EST
Conference dial-in:
U.S.: (877) 303-1595
International: (970) 315-0449
Conference ID: 70941792
Webcast: http://ir.visionsciences.com/
An audio replay of the conference call will be available from 11:30 a.m. EST on Thursday, February 5, 2015, through 11:59 p.m. EST on Thursday, February 19, 2015, by dialing (855) 859-2056 from the U.S. or (404) 537-3406 from abroad. The audio webcast will also be available in the investor section of the Company's website, www.visionsciences.com.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. The Company's unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, providing users with efficient and cost effective endoscope turnover while enhancing patient safety. Information about Vision-Sciences' products is available at www.visionsciences.com.
Vision-Sciences owns the registered trademarks Vision Sciences(R), EndoSheath(R), EndoWipe(R), Slide-On(R), and The Vision System(R).
Contacts:
Gary Siegel
Vice President, Finance
Vision-Sciences, Inc.
(845) 365-0600
[email protected]
Lisa Wilson
President
In-Site Communications, Inc.
(212) 452-2793
[email protected]
SOURCE: Vision-Sciences, Inc.